The European Union’s medicines authority says it has begun evaluating a new drug for treating COVID-19 patients who do not require extra oxygen but are at increased risk of developing severe symptoms of the disease
Related posts
-
Johnson grateful for support and trust in winning second term in close race for Libertyville mayor
The race for Libertyville mayor Tuesday was neck and neck most of the evening before Donna... -
Kane County Cougars introduce new ownership
The message Wednesday morning was clear: Kane County Cougars fans can expect the same team they... -
Wheaton’s French market back in action April 12
In a sign that spring has sprung, Wheaton’s French market will open for the season Saturday,...